Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06044610 · ClinicalTrials.gov registry record · NA
Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
A NA study of Dehydration, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT06044610 is a NA study of Dehydration that has completed, run by PepsiCo Global R&D. The registered enrollment target is 32 participants, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06044610, a NA study of Dehydration, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.
Conditions Studied
Interventions
- OTHER GENPOP Passive dehydration (75% reduction in fluid intake
- OTHER GENPOP Ad lib fluid intake
- OTHER EXERCISE without fluid replacement
- OTHER EXERCISE with fluid replacement
Study Locations (2)
New York
- PepsiCo R&D, Gatorade Sports Science Institute - Valhalla
Texas
- PepsiCo R&D, Gatorade Sports Science Institute - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2023-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06044610
The ClinicalTrials.gov registry entry for NCT06044610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (43% lower). The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 4 interventions - of which GENPOP Passive dehydration (75% reduction in fluid intake is the first listed.
NCT06044610 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.
Frequently Asked Questions
What is clinical trial NCT06044610 about?
NCT06044610 is a clinical study titled "Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development". The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydrat...
What is the current status of trial NCT06044610?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-05-08. Estimated completion is 2023-11-15.
What conditions does trial NCT06044610 study?
This clinical trial studies the following conditions: Dehydration.
What interventions are being tested in trial NCT06044610?
The interventions under investigation include: GENPOP Passive dehydration (75% reduction in fluid intake (OTHER), GENPOP Ad lib fluid intake (OTHER), EXERCISE without fluid replacement (OTHER), EXERCISE with fluid replacement (OTHER).
Who is sponsoring clinical trial NCT06044610?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06044610 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dehydration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Efficacy of Education Versus Education Plus Prescribed Fluid Intake on Hydration Status in High School Athletes
RECRUITING · NA
-
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
RECRUITING · NA
-
Adequate Hydration and Health Outcomes
RECRUITING · NA
-
Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults
ACTIVE NOT RECRUITING · NA
-
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.